TAK 044 structure
|
Common Name | TAK 044 | ||
---|---|---|---|---|
CAS Number | 157380-72-8 | Molecular Weight | 971.98 | |
Density | N/A | Boiling Point | 1421.4ºC at 760mmHg | |
Molecular Formula | C45H51N9Na2O11S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 813.4ºC |
Use of TAK 044TAK 044 is an antagonist of Endothelin Receptor. TAK 044 strongly inhibits ET-induced deterioration in various animal models. TAK 044 can be used in study ET-related diseases such as acute myocardial infarction,acute renal failure, acute hepatic malfunction, and subarachnoid hemorrhage[1]. |
Name | disodium,2-[(2R,5S,8S,11S,14S,17R)-8-(carboxylatomethyl)-17-(1H-indol-3-ylmethyl)-14-(2-methylpropyl)-3,6,9,12,15,18-hexaoxo-5-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-11-thiophen-2-yl-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetate |
---|---|
Synonym | More Synonyms |
Description | TAK 044 is an antagonist of Endothelin Receptor. TAK 044 strongly inhibits ET-induced deterioration in various animal models. TAK 044 can be used in study ET-related diseases such as acute myocardial infarction,acute renal failure, acute hepatic malfunction, and subarachnoid hemorrhage[1]. |
---|---|
Related Catalog | |
References |
[1]. Toshifumi Watanabe, et al. TAK-044: An Endothelin Receptor Antagonist. , 14(1), 36–46. |
Boiling Point | 1421.4ºC at 760mmHg |
---|---|
Molecular Formula | C45H51N9Na2O11S |
Molecular Weight | 971.98 |
Flash Point | 813.4ºC |
Exact Mass | 971.32200 |
PSA | 343.38000 |
Vapour Pressure | 0mmHg at 25°C |
Cyclo(atsptpal) |
Cyclo(asparaginyl-threonyl-seryl-phenylalanyl-threonyl-prolyl-arginyl-leucyl) |
cyclo[NTSFTPRL] |
(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-N-[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-formylpyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,3-dioxopropan-2-yl]amino]-3-hydroxy-1 |
cyclo[Asn1]LPK |
Leucopyrokinin,1-L-asparagine-8-L-leucine-,cyclic (B-1)-peptide |
Cyclo(asn-thr-ser-phe-thr-pro-arg-leu) |